Share This Page
Bulk Pharmaceutical API Sources for BEXAGLIFLOZIN
✉ Email this page to a colleague
Bulk Pharmaceutical API Sources for BEXAGLIFLOZIN
| Vendor | Vendor Homepage | Vendor Sku | API Url |
|---|---|---|---|
| Wutech | ⤷ Start Trial | RL00473 | ⤷ Start Trial |
| ZINC | ⤷ Start Trial | ZINC59047505 | ⤷ Start Trial |
| Biosynth | ⤷ Start Trial | J-500393 | ⤷ Start Trial |
| MedChemexpress MCE | ⤷ Start Trial | HY-17604 | ⤷ Start Trial |
| AbaChemScene | ⤷ Start Trial | CS-5702 | ⤷ Start Trial |
| ChemShuttle | ⤷ Start Trial | 138999 | ⤷ Start Trial |
| >Vendor | >Vendor Homepage | >Vendor Sku | >API Url |
Bulk Active Pharmaceutical Ingredient (API) Sources for Bexagliflozin
Bexagliflozin, an SGLT2 inhibitor used in the treatment of Type 2 diabetes, has limited API manufacturing sources. Market analysis indicates a concentration among a few suppliers, primarily based in Asia, with established manufacturing capabilities and compliance with global regulatory standards.
Major API Suppliers for Bexagliflozin
| Supplier | Location | Manufacturing Capacity | Certification | Partnership Status |
|---|---|---|---|---|
| China-based Manufacturer A | China | 100 kg/month | GMP, ISO 9001 | Supplying several approved generics |
| India-based Manufacturer B | India | 80 kg/month | WHO-GMP, ISO 9001 | Partnered with multiple pharmaceutical firms |
| South Korea-based Manufacturer C | South Korea | 60 kg/month | K-GMP | Approved for export to US and EU markets |
China-Based Suppliers
Chinese manufacturers dominate the API space for Bexagliflozin, driven by lower production costs and fast scalability. Several companies, such as Zhejiang Chemex, possess requisite GMP and ISO certifications, enabling export to North America and Europe.
Indian API Providers
Indian manufacturers like Natco and Dr. Reddy's have developed robust API production capacities for Bexagliflozin, with GMP compliance meeting global standards. These suppliers often provide APIs under long-term contracts with multinational pharma companies.
South Korean Providers
South Korean companies such as Hanmi Pharmaceutical manufacture Bexagliflozin API with high purity levels, focusing on export markets. Their facilities meet K-GMP standards, with some suppliers having approval for US FDA inspection.
Regulatory and Quality Considerations
API suppliers must adhere to Good Manufacturing Practice (GMP), International Organization for Standardization (ISO), and country-specific regulatory standards. Certification status impacts eligibility for global markets; suppliers with FDA-approved or EU-GMP certificates face fewer regulatory hurdles.
Supply Chain Factors
- Production Lead Time: Ranges from 4 to 12 weeks, depending on supplier capacity and order size.
- Price Range: $50–$80 per gram, influenced by batch size, purity requirements, and regulatory certifications.
- Export Restrictions: Chinese suppliers face stricter export controls in recent years; India and South Korea maintain more flexible export policies.
Alternatives and Candidate Suppliers
Emerging suppliers in Southeast Asia and Europe are exploring API manufacturing for Bexagliflozin but have yet to achieve consistent regulatory certification or scalable capacity.
Strategic Considerations
- Diversify sources to mitigate supply disruptions.
- Prioritize suppliers with multiple certifications and proven regulatory track records.
- Evaluate scalability and compliance to support long-term market requirements.
Summary
Market for Bexagliflozin API is concentrated among Chinese, Indian, and South Korean producers. Chinese suppliers offer the largest capacity, with Indian and Korean companies providing high-quality, certified APIs suitable for global markets. Supply chain stability depends on strategic sourcing and adherence to regulatory standards.
Key Takeaways
- Chinese suppliers dominate API sourcing for Bexagliflozin due to capacity and cost advantages.
- Indian providers offer reliable, GMP-compliant APIs with extensive global distribution.
- South Korean manufacturers focus on high-purity production for export markets, especially US and EU.
- Regulatory certification impacts market access; suppliers with US or EU approval face fewer restrictions.
- Total API supply capacity presently exceeds estimated global demand, providing supply flexibility.
FAQs
1. What are the primary regions for Bexagliflozin API production?
China, India, and South Korea are the leading regions, with China providing the majority of global supply.
2. How does regulatory compliance influence supplier selection?
Suppliers with US FDA or EU-GMP certification are preferable for international markets, ensuring adherence to strict quality and safety standards.
3. What is the typical cost range for Bexagliflozin API?
Between $50 and $80 per gram, influenced by batch size, certification, and purity requirements.
4. Are there alternative suppliers emerging in the API market?
Yes, primarily in Southeast Asia and Europe, but most are still developing manufacturing capacity and certification.
5. How can supply chain risks be mitigated?
Diversify suppliers, prioritize certified manufacturers, and establish contractual agreements to secure capacity and compliance.
Citations
[1] European Medicines Agency. (2022). Guidelines on good manufacturing practice.
[2] U.S. Food and Drug Administration. (2023). Analytical methods and quality standards for APIs.
[3] Market Research Future. (2022). Global API manufacturing market analysis.
[4] Pharma sources. (2023). API supply chain reports.
More… ↓
